Putney Launches Generic Ketamine, Other Products In Pipeline



Published:

Putney Inc. of Portland, Maine, reported today that the U.S. Food and Drug Administration’s Center of Veterinary Medicine has approved its generic ketamine hydrochloride for injection.

Additional launches of generic pet medications are to follow, including analgesics, anti-infectives, anesthetics, sedatives, dermatologicals and parasiticides, according to Anthony Lucas, BVMS, Ph.D., senior director of product development.

Today’s launch follows the company’s carprofen caplet introduction in 2009. Since then, Putney has advanced its research and development pipeline of generic pet pharmaceutical products for submission to CVM.

These rollouts are just the beginning, Dr. Lucas said.

Putney’s ketamine hydrochloride, which comes in 10 mL vials (100 mg/mL), is indicated for use in cats for restraint or as the sole anesthetic agent for diagnostic or minor, brief, surgical procedures that do not require skeletal muscle relaxation, according to the product’s label. It may also be used in subhuman primates for restraint.

Distributors currently carrying the product include D-V Medical Supply Inc., First Veterinary Supply, PCI Animal Health, Victor Medical Co. and Webster Veterinary.

<Home>

 

Archive »Read More

Sleepypod Dog Harness Earns Top Rating From Safety Group

The new Clickit Sport was evaluated under the Center for Pet Safety’s Harness Certification Program.

Kindred Unsuccessful With First Canine Drug

Kindred’s CereKin osteoarthritis medication did not perform up to expectations.

The Pet Industry Agrees: More Pet Insurance Regulation in California Is a Good Thing

Dababneh Assembly Bill 2056 is the answer to the California insurance commissioner calls for more pet insurance regulation.

Add your comment:

Events


Show More...